Efficacy and Safety of Long-Acting β-Agonist/Long-Acting Muscarinic Antagonist Combinations Compare to Long-Acting β-Agonist/Inhaled Corticosteroid Combinations: A Network Meta-Analysis

被引:0
|
作者
Ahmed, T. Said [1 ]
Al-Sarie, M. [2 ]
Srour, K. [2 ]
Rygielski, S. [3 ]
Ye, F. [2 ]
Hernandez, D. [4 ]
机构
[1] Univ Toledo, Crit Care Pulm, 2801 W Bancroft St, Toledo, OH 43606 USA
[2] Univ Toledo, Internal Med, 2801 W Bancroft St, Toledo, OH 43606 USA
[3] Univ Toledo, Anesthesia, 2801 W Bancroft St, Toledo, OH 43606 USA
[4] Univ Toledo, Med Ctr, Pulm Crit Care Sleep Med, 2801 W Bancroft St, Toledo, OH 43606 USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A3045
引用
收藏
页数:2
相关论文
共 50 条
  • [11] COMPARISON OF "OPEN TRIPLE" COMBINATIONS OF INHALED LONG-ACTING MUSCARINIC ANTAGONIST, LONG-ACTING B2-AGONIST AND AN INHALED CORTICOSTEROID IN PATIENTS WITH ASTHMA, COPD AND ASTHMA-COPD OVERLAP
    Mochizuki, Taichi
    Inoue, Yasushi
    Arai, Hiroyuki
    Ueda, Ryuta
    Nagase, Seisuke
    Umeda, Akira
    Tsushima, Kenji
    RESPIROLOGY, 2019, 24 : 162 - 163
  • [12] Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β2-Agonist Combinations in Patients With COPD
    Chang, Ting-Yu
    Chien, Jung-Yien
    Wu, Chung-Hsuen
    Dong, Yaa-Hui
    Lin, Fang-Ju
    CHEST, 2020, 157 (05) : 1117 - 1129
  • [13] Comparisons of Efficacy and Safety between Triple (Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist) Therapies in Chronic Obstructive Pulmonary Disease: Systematic Review and Bayesian Network Meta-Analysis
    Lee, Hyun Woo
    Kim, Hyung Jun
    Jang, Eun Jin
    Lee, Chang-Hoon
    RESPIRATION, 2021, 100 (07) : 631 - 643
  • [14] BECLOMETASONE/FORMOTEROL/GLYCOPYRRONIUM VS. FIXED AND OPEN COMBINATIONS OF INHALED CORTICOSTEROIDS, LONG-ACTING B2-AGONIST, AND LONG-ACTING MUSCARINIC ANTAGONIST IN ADULTS WITH UNCONTROLLED ASTHMA: A NETWORK META-ANALYSIS
    Orlovic, M.
    Nikolaidis, G.
    Tzelis, D.
    Barouma, I
    Vele, A.
    Kots, M.
    van der Deijl, M.
    Madoni, A.
    VALUE IN HEALTH, 2023, 26 (12) : S159 - S160
  • [15] Comparative Effectiveness of Long-Acting Beta2-Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease
    Samp, Jennifer C.
    Joo, Min J.
    Schumock, Glen T.
    Calip, Gregory S.
    Pickard, A. Simon
    Lee, Todd A.
    PHARMACOTHERAPY, 2017, 37 (04): : 447 - 455
  • [17] Effect of Adding Inhaled Corticosteroid to Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist Therapy Among Patients With Chronic Obstructive Pulmonary Disease
    Yuasa, Mizuki
    Tanaka, Yosuke
    Tanaka, Tohru
    Kashiwada, Takeru
    Taniuchi, Namiko
    Saito, Yoshinobu
    Seike, Masahiro
    Hino, Mitsunori
    Gemma, Akihiko
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [18] Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting 2-agonists: a systematic review and network meta-analysis
    Schlueter, Max
    Gonzalez-Rojas, N.
    Baldwin, Michael
    Groenke, Lars
    Voss, Florian
    Reason, Tim
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2016, 10 (02) : 89 - 104
  • [19] A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease
    Masato Muraki
    Yuki Kunita
    Ken Shirahase
    Ryo Yamazaki
    Soichiro Hanada
    Hirochiyo Sawaguchi
    Yuji Tohda
    BMC Pulmonary Medicine, 21
  • [20] A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease
    Muraki, Masato
    Kunita, Yuki
    Shirahase, Ken
    Yamazaki, Ryo
    Hanada, Soichiro
    Sawaguchi, Hirochiyo
    Tohda, Yuji
    BMC PULMONARY MEDICINE, 2021, 21 (01)